Kozak & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Kozak & Associates's LLY Position: Q3 2026 in Review
Kozak & Associates held its Eli Lilly (LLY) position steady in Q3 2026 at 50 shares worth $64.8K. The position accounts for 0.01% of the portfolio, ranked #125.
Kozak & Associates first reported a position in LLY in Q3 2021 and has held it in 21 quarters since. 4,628 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Kozak & Associates held 50 shares of Eli Lilly worth $64.8K as of Q3 2026.
- Kozak & Associates left its Eli Lilly share count unchanged in Q3 2026.
- Eli Lilly made up 0.01% of Kozak & Associates's portfolio in Q3 2026, its #125 holding.
- Kozak & Associates first reported a position in Eli Lilly in Q3 2021 and has held it in 21 quarters since.
- 4,628 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Kozak & Associates's 13F filing for Q3 2026, filed 29 Oct 2026.